Text of amendments, recommended by the committee on Ways and Means, to the Senate Bill relative to pharmaceutical access, costs and transparency (Senate, No. 2520). July 22, 2024.
Bill History
| Date | Branch | Action |
|---|---|---|
| 7/22/2024 | House | Text of an amendment, see S2520 |
| 7/24/2024 | House | Consolidated amendment A adopted - 158 YEAS to 0 NAYS (See YEA and NAY No. 141 ) |
| 7/24/2024 | House | Published as amended, see H4910 |
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.